SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-041477
Filing Date
2020-04-01
Accepted
2020-04-01 06:14:31
Documents
12
Period of Report
2020-03-28
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2014406d1-8k.htm   iXBRL 8-K 36144
  Complete submission text file 0001104659-20-041477.txt   213605

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA akrx-20200328.xsd EX-101.SCH 3177
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20200328_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20200328_pre.xml EX-101.PRE 22704
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2014406d1-8k_htm.xml XML 3587
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 20763656
SIC: 2834 Pharmaceutical Preparations